About Maxymune Therapeutics
Maxymune Therapeutics is a private company based in Los Altos, California, incorporated in 2023 in Delaware. It has reported $2,675,000 raised in one offering on Form D since February 2025.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 11, 2025 | Feb 28, 2025amended Jun 3, 2026 | $2,675,000of $4.5M target | 15 | $178K | OptionsRule 506(b) | Form D/A ↗1 earlier filing |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Maxymune Therapeutics's Form D filed Jun 3, 2026.
